SOPHIA
Stratification of obese phenotypes to optimize future obesity therapy
Site Search
Site Search
Displaying results 221 - 230 of 893
EUbOPEN
EUbOPEN: Enabling and unlocking biology in the OPEN
Regulatory decision gives boost to development of potential new TB drug
A decision by US regulators is set to speed up reviews of a potential new TB drug being developed by IMI’s TRIC-TB project.
Previous IMI investments are proving prescient in the current COVID-19 crisis
Investment in AMR, vaccines and infectious disease preparedness research are proving extremely prescient in the current pandemic, as are the relationships and networks we’ve built around the globe.
IMI Stakeholder Forum 2020
The IMI Stakeholder Forum 2020 took place online on Tuesday 10 November. The theme this year was 'Broader horizons: growing Europe’s health partnership' . We launched the last calls for IMI2 this year, and the Stakeholder Forum allowed us to take stock of what was achieved, and ...
IMI-supported Ebola vaccine regimen gets green light
The European Commission has officially granted market authorisation for an IMI-supported Ebola vaccine regimen, which represents a vital tool in the fight against the deadly disease.
Focus on: autoimmune diseases
During the month of June we took a look at some of our autoimmune disease research projects.
IMI launches final IMI2 Calls for proposals
Brussels, Belgium, 23 June 2020 – Today, the Innovative Medicines Initiative (IMI) is launching the last Calls for proposals under the IMI2 programme, with topics on tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare ...
Unprecedented study of inflammatory skin disease data gets underway
IMI’s BIOMAP project is gathering data from previous and ongoing clinical studies to try to find out what lies beneath inflammatory skin ailments like psoriasis and atopic dermatitis
